Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
07/01/1997 | US5643578 Subunit vaccines |
07/01/1997 | US5643577 Oral vaccine comprising antigen surface-associated with red blood cells |
07/01/1997 | US5643576 Method of inducing an immune response with a live Venezuelan Equine Encephalitis virus expressing a heterologous immunogen |
06/26/1997 | WO1997022722A1 Genetic suppressor elements against human immunodeficiency virus |
06/26/1997 | WO1997022701A1 Equine rhinovirus 1 proteins |
06/26/1997 | WO1997022698A2 Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies |
06/26/1997 | WO1997022688A1 Heterophil-adapted poultry vaccine |
06/26/1997 | WO1997022623A1 Osteo antiviral protein |
06/26/1997 | WO1997022619A2 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
06/26/1997 | WO1997022618A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
06/26/1997 | WO1997022613A1 Phospholipid derivatives of phosphono-carboxylic acids, the production of said derivatives and the use of said derivatives as antiviral medicaments |
06/26/1997 | WO1997022368A2 Covalent lipid-phosphono-carboxylic acid conjugates and application thereof as antiviral medicaments |
06/26/1997 | WO1997022354A2 Use of a medicament and use of mixture of substances to produce a medicament |
06/26/1997 | WO1997022346A2 Use of sugar derivatives as antimicrobial, antimycotic and/or antiviral active substances |
06/26/1997 | WO1997022250A1 Therapeutic molecules generated by trans-splicing |
06/26/1997 | WO1997022248A1 Composition for organ cryopreservation and treatment of viral and bacterial infections |
06/26/1997 | WO1997013845A3 Phosphopantetheinyl transferases and uses thereof |
06/26/1997 | DE19608753C1 Transduction system based on rep-negative adeno-associated virus vector |
06/26/1997 | DE19548624A1 Neue Barbitursäure-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel New barbituric acid derivatives, processes for their preparation and medicaments containing these compounds |
06/26/1997 | CA2241371A1 Genetic suppressor elements against human immunodeficiency virus |
06/26/1997 | CA2240729A1 Use of a medicament and use of mixture of substances to produce a medicament |
06/26/1997 | CA2240489A1 Inhibitors of interleukin-1.beta. converting enzyme |
06/26/1997 | CA2240366A1 New phospholipid derivatives of phosphonocarboxylic acids, the production thereof as well as their use as antiviral pharmaceutical agents |
06/26/1997 | CA2240365A1 Covalent lipid-phosphono-carboxylic acid conjugates and application thereof as antiviral medicaments |
06/26/1997 | CA2240131A1 Composition for organ cryopreservation and treatment of viral and bacterial infections |
06/25/1997 | EP0780393A1 Novel crystal of cephalosporin compound |
06/25/1997 | EP0780390A1 Crystalline modification of CDCH, process for its preparation and pharmaceutical compositions containing it |
06/25/1997 | EP0780122A1 Depressant of functions developed by molecule |
06/25/1997 | EP0779923A2 Interleukin-1 type 3 receptors |
06/25/1997 | EP0779893A2 Oligonucleotide prodrugs |
06/25/1997 | EP0779885A1 Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring |
06/25/1997 | EP0779819A1 Therapeutic treatment of clostridium difficile associated diseases |
06/25/1997 | EP0779817A1 Enteral vaccine for vaginal infections |
06/25/1997 | EP0656886B1 N-(alkanoylamino-2-hydroxypropyl)-sulfonamides useful as retroviral protease inhibitors |
06/25/1997 | EP0556248B1 Mycobacterium as adjuvant for antigens |
06/25/1997 | EP0538486B1 Sewing machine needle and method of manufacturing same |
06/25/1997 | CN1152940A Non-splicing variants of gp 350/220 |
06/25/1997 | CN1152935A Papillomavirus vaccines |
06/25/1997 | CN1152916A Trifluoromethylquinoline carboxylic acid derivative |
06/25/1997 | CN1152910A Difluorostatone antiviral agents |
06/25/1997 | CN1152878A Improved modified live BRSV vaccine |
06/25/1997 | CN1152871A Methods of use for peroxynitrite decompositionc atalysts, pharmaceutical compositions therefor |
06/25/1997 | CN1152866A Soap composition |
06/25/1997 | CN1152575A New cephalosporing containing in position 7 substituted benzyloxyimino radical, their preparation process and intermediates, their use as medicaments |
06/25/1997 | CN1152435A Medicinal products containing antimer pure beta-D-dioxypentacyclic nucleoside |
06/24/1997 | US5641889 Therapeutic nucleosides |
06/24/1997 | US5641886 Process for preparation of N-tert.butyl-decahydro-2-[2(R)-hydroxy-4-phenyl-3(S)-phthalimidobutyl]-(4AS,8AS)-isoquinoline-3(S)-carboxamide |
06/24/1997 | US5641875 Dna construct encoding immunoglobulin g fc receptor comprising extracellular, transmembrane and cytoplasmic domains or functional portions thereof, which renders phagocytic cell comprising same |
06/24/1997 | US5641874 DNA encoding bactericidal/permeability increasing proteins |
06/24/1997 | US5641863 Immunoglobulin g fc receptor comprising extracellular, transmembrane and cytoplasmic domains or functional portions thereof, which renders phagocytic cells comprising same |
06/24/1997 | US5641800 Alleviate effect of septic shock, adult respiratory distress syndrome, pancreatitis, trauma, bronchial asthma, allergic rhinitis, and rheumatoid arthritis |
06/24/1997 | US5641770 Thienamycins antibiotics |
06/24/1997 | US5641763 N-phosphonylmethoxyalkyl derivatives of pyrimdine and purine bases and a therapeutical composition therefrom with antiviral activity |
06/24/1997 | US5641761 Feeding crustacea food containing water-soluble schizophyllan and mycelia of schizophyllan-producing fungus |
06/24/1997 | US5641760 Method of treating candida infection |
06/24/1997 | US5641669 Platelet-activating factor acetylhydrolase |
06/24/1997 | US5641662 Transfection of lung via aerosolized transgene delivery |
06/24/1997 | US5641657 DNA encoding an interleukin-6 splice variant |
06/24/1997 | US5641653 Producing antigens used for vaccinating pigs against pleuropneumonia |
06/24/1997 | US5641625 Peptide nucleic acids forming duplex, triplex and other structures with nucleic acids; modulation of protein activity by transcription arrest and initiation; specific site cleavage |
06/24/1997 | US5641497 Gastrointestinal defensins, cDNA sequences and method for the production and use thereof |
06/24/1997 | US5641492 Broad spectrum vaccine for immunizing animals against gramnegative bacteria comprising killed suspension of bacterial mutant, detoxified lipopolysaccharide immune modulator, protein and lipid binding carrier |
06/24/1997 | US5641491 Escherichia coli strain 364 and use of said strain as a vaccine |
06/24/1997 | US5641485 Caledothricins used in the treatment mycotic diseases |
06/24/1997 | US5641475 Antiodor, antimicrobial and preservative compositions and methods of using same |
06/19/1997 | WO1997021819A1 Novel nagpu |
06/19/1997 | WO1997021815A2 Antifungal proteins |
06/19/1997 | WO1997021814A1 Antifungal proteins |
06/19/1997 | WO1997021727A1 Mycoplasma recombinant polypeptide vaccines |
06/19/1997 | WO1997021712A1 Carbapenem-3-carboxylic acid ester derivatives |
06/19/1997 | WO1997021708A1 4-pyrimidinyl- or 4-pyrazinyl-piperazinyl-phenyl-oxazolidinone derivatives, their preparation and their use as anti-bacterial agents |
06/19/1997 | WO1997021685A1 Retroviral protease inhibiting compounds |
06/19/1997 | WO1997021684A1 Use of tricyclic 1,4-dihydro-1,4-dioxo-1h-naphthalene derivatives, resulting novel compounds and therapeutical use thereof |
06/19/1997 | WO1997021683A1 Retroviral protease inhibiting compounds |
06/19/1997 | WO1997021444A1 Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof |
06/19/1997 | WO1997021431A1 Cobalt schiff base compounds |
06/19/1997 | WO1997011666A3 Use of 2-mercaptoethanolamine (2-mea) and related aminothiol compounds and copper(ii)-3,5 di-isopropyl salicylates and related compounds in the prevention and treatment of various diseases |
06/19/1997 | DE19547160A1 Verwendung von Zuckerderivaten als antimikrobiell, antimykotisch und/oder antivirale Wirkstoffe Use of sugar derivatives as antimicrobial, antifungal and / or antiviral agents |
06/19/1997 | DE19547022A1 Kovalente Lipid-Phosphonocarbonsäure-Konjugate, deren Herstellung sowie deren Verwendung als antivirale Arzneimittel Covalent lipid phosphonocarboxylic acid conjugates, their preparation and their use as antiviral drugs |
06/19/1997 | CA2509505A1 Retroviral protease inhibiting compounds |
06/19/1997 | CA2273983A1 Process for the preparation of 9-deazaguanine derivatives |
06/19/1997 | CA2240279A1 Use of tricyclic 1,4-dihydro-1,4-dioxo-1h-naphthalene derivatives, resulting novel compounds and therapeutical use thereof |
06/19/1997 | CA2240183A1 Cobalt schiff base compounds |
06/19/1997 | CA2239874A1 Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof |
06/19/1997 | CA2239873A1 Antifungal proteins |
06/19/1997 | CA2239731A1 Antifungal proteins |
06/19/1997 | CA2238977A1 Retroviral protease inhibiting compounds |
06/19/1997 | CA2211075A1 Carbapenem-3-carboxylic acid ester derivatives |
06/18/1997 | EP0779365A2 Methods to introduce nucleic acid into cells for therapeutic and diagnostic uses |
06/18/1997 | EP0779291A1 Heterocyclylcarbonyl substituted benzofuranyl-ureas |
06/18/1997 | EP0778894A1 Infectious peritonitis vaccine |
06/18/1997 | EP0778847A1 Immunostimulatory agents |
06/18/1997 | EP0778845A1 Oligonucleotide conjugates, compositions and methods for splitting ribonucleic acids |
06/18/1997 | EP0778843A1 Intermediates for dinucleotide and oligonucleotide analogues |
06/18/1997 | EP0778780A1 Capsular polysaccharide immunomodulator |
06/18/1997 | EP0778776A1 Hyaluronic acid and derivatives for modulation of cellular activity |
06/18/1997 | EP0778733A1 A basic protein composition for killing or inhibiting microbial cells |
06/18/1997 | EP0778731A1 Ionene polymers containing biologically-active anions |
06/18/1997 | EP0701562B1 Unsaturated phosphonates derivatives of purines and pyrimidines |
06/18/1997 | EP0580635B1 Modified plant viruses as vectors |